Effective in closing transactions
Our long-standing experience and a global network of offices allow us to ensure for our clients the best terms in transactions.
See below selected transactions from recent years.
Touch to read more.
Buy-side Advice
Acquisition of 100% shares
Target company
2023 - USA
Transaction advisory to RE3DTECH, a portfolio company of Core Industrial Partners, on the acquisition of Stanfordville Machine and Manufacturing
MoreBuy-side Advice
Acquisition of 100% shares
Target company
2023 - Italy
Transaction advisory to Pedrollo Group on the acquisition of Saci Pumps
MoreSell-side Advice
Sale of 100% shares
Investor
2023 - USA
Transaction advisory to Trans Ash Inc, on the sale to NorthStar Group, a portfolio company of J.H. Lehman & Company
MoreBuy-side Advice
Acquisition of 100% shares
Target company
2023 - USA
Transaction advisory to Mytee Product, Inc, a portfolio company of Dry Fly Capital on the acquisition of Square Scrub
MoreBuy-side Advice
Acquisition of 100% shares
Target company
2023 - Sweden
Transaction advisory to Miss Group on the acquisition of SERED
MoreSell-side Advice
Sale of the majority of the shares
Investor
2022 - Poland
Transaction advisory to the owners of Elektrotermex (ETX) on gaining Viessmann strategic investor
MoreBuy-side Advice
Acquisition of 100% shares
Target company
2022 - Poland
M&A advisory to owners of Klinika Bocian – the leading centers providing infertility treatment, gynecology and obstetrics services in Poland – in the process of purchase of...
MoreSell-side Advice
Sale of 100 % shares
Investor
2022 - Poland
Transaction advisory to JCommerce's owners on sale of 100% shares of the company to Inetum Group
MoreBuy-side Advice
Acquisition of 100% shares
Target company
2022 - France
Capital advisory to Barentz, the global life science ingredients distributor, in the process of acquisition of Unipex Group
MoreSell-side Advice
Majority stake sale
Investor
2022 - Finland
Transaction advisory to the owners of Studeo on gaining Klett Group strategic investor
MoreSell-side Advice
Sale of 100% shares
Investor
2022 - United Kingdom
Translink advised Peak Proteins of the 100% sale to Sygnature Discovery
MoreSell-side Advice
Sale of subsidiaries
Investor
2022 - Spain